VAERS reports by lot

Merck HPV lot R003557: VAERS reports

24 VAERS reports list lot R003557 as a Merck HPV vaccine, received between 2018-06-27 and 2022-02-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1227%
Injection-site / Local reaction1023%
Gastrointestinal818%
General / Systemic (non-local)614%
Musculoskeletal37%
Cardiac / Cardiovascular25%
Autoimmune / Immune-mediated12%
Allergic / Anaphylactic12%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Texas3
Montana2
New York2
New Mexico1
Colorado1
Pennsylvania1
Missouri1
Alabama1
Florida1
Illinois1
Georgia1

Reports by month received

2018-061
2018-072
2018-093
2018-103
2018-111
2018-122
2019-011
2019-021
2019-031
2019-041
2019-051
2019-061
2019-082
2020-121
2021-011
2021-021
2022-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.